Christopher Garbett
Papers
1
Total Citations
255
H-Index
1
About
Christopher Garbett is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for colorectal cancer treatment, with a particular emphasis on robotic-assisted surgery. His most impactful contribution is the landmark ROLARR trial, an international, multicentre, prospective, randomised controlled study comparing robotic-assisted versus standard laparoscopic surgery for rectal cancer. This seminal work, published in 2011 and cited over 255 times, provided critical evidence on the efficacy and safety of robotic approaches, helping to shape clinical guidelines and surgical practice worldwide. Garbett’s research has directly influenced the adoption of robotic platforms in complex pelvic surgery, improving patient outcomes through reduced complications and better oncological clearance. Beyond this trial, his work spans surgical innovation, perioperative care, and health services research, consistently driving evidence-based improvements in cancer surgery. With a career dedicated to rigorous clinical investigation, Garbett has become a trusted voice in the field, mentoring the next generation of surgeons and contributing to international consensus on best practices for rectal cancer management.
Research Focus
Key Achievements
Top Papers
- 1